Hexagon Bio

Verified by our team

  • Biotech
Linkedin Twitter Facebook

Hexagon Bio is a biopharma company using data science, genomics, and synthetic biology to develop targeted small molecule therapeutics. By mining fungal genomes, they aim to discover novel therapies for diseases with unmet needs.

Hexagon Bio Highlights:

  • Hexagon Bio annual revenue is $16.4M.
  • Hexagon Bio total funding is $206.0M.
  • Hexagon Bio headquartered in Menlo Park, California.
  • Hexagon Bio number of employees is 106.

    • Overview

    • Website: hexagonbio.com
    • Headquarters: Menlo Park, California
    • Employees: 106
    • Founded: 2017
    • Email: info@hexagonbio.com
    • Funding: $206.0M
    • Revenue: $16.4M
    • Valuation: n/a

    Contacts

    Maureen Hillenmeyer

    Founder and CEO
    Linkedin
    • Email: ***@hexagonbio.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to Hexagon Bio

    Hexagon Bio is located in Menlo Park, California.
    Yes, Hexagon Bio is a Silicon Valley company.
    Hexagon Bio total funding is 206.0M.
    Hexagon Bio revenue is 16.4M.
    Hexagon Bio’s number of employees is 106.
    Hexagon Bio’s CEO name is Maureen Hillenmeyer.
    Hexagon Bio was founded in 2017.
    Hexagon Bio’s contact email is info@hexagonbio.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ